Ensign Peak Advisors’s Insmed INSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $56.8M | Sell |
564,389
-25,010
| -4% | -$2.52M | 0.1% | 185 |
|
|
2025
Q1 | $45M | Buy |
589,399
+60,350
| +11% | +$4.6M | 0.09% | 200 |
|
|
2024
Q4 | $36.5M | Buy |
529,049
+44,928
| +9% | +$3.1M | 0.06% | 221 |
|
|
2024
Q3 | $35.3M | Buy |
484,121
+125,092
| +35% | +$9.13M | 0.06% | 223 |
|
|
2024
Q2 | $24.1M | Buy |
359,029
+17,455
| +5% | +$1.17M | 0.04% | 281 |
|
|
2024
Q1 | $9.27M | Buy |
341,574
+271,564
| +388% | +$7.37M | 0.02% | 472 |
|
|
2023
Q4 | $2.17M | Buy |
70,010
+4,340
| +7% | +$134K | ﹤0.01% | 885 |
|
|
2023
Q3 | $1.66M | Hold |
65,670
| – | – | ﹤0.01% | 897 |
|
|
2023
Q2 | $1.39M | Hold |
65,670
| – | – | ﹤0.01% | 1023 |
|
|
2023
Q1 | $1.12M | Sell |
65,670
-233,553
| -78% | -$3.98M | ﹤0.01% | 1153 |
|
|
2022
Q4 | $5.98M | Buy |
299,223
+88,100
| +42% | +$1.76M | 0.01% | 521 |
|
|
2022
Q3 | $4.55M | Buy |
211,123
+49,426
| +31% | +$1.06M | 0.01% | 542 |
|
|
2022
Q2 | $3.19M | Buy |
161,697
+116,937
| +261% | +$2.31M | 0.01% | 648 |
|
|
2022
Q1 | $1.05M | Buy |
44,760
+16,600
| +59% | +$390K | ﹤0.01% | 1175 |
|
|
2021
Q4 | $767K | Buy |
+28,160
| New | +$767K | ﹤0.01% | 1413 |
|